Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma.
Xiang-Rong NiCheng-Cheng GuoYan-Jiao YuZhi-Hui YuHai-Ping CaiWei-Chi WuJun-Xiao MaFu-Rong ChenJing WangZhong-Ping ChenPublished in: Cancer chemotherapy and pharmacology (2020)
The combination use of LEV and IFN-α could be an optimal method to overcome TMZ resistance through obvious MGMT inhibition in MGMT-positive glioma.